Navigation Links
Late peak may have prevented severe flu season from becoming worse

The 2004-2005 flu season was at least as severe as the 2003-2004 season, but peaked later according to data from Solucient, a leading provider of healthcare information. This later peak may have prevented the most recent flu season from being even worse.

A flu season's severity is reflected in hospital admissions for community-acquired pneumonia (CAP), one of the most common complications of the flu. Solucient analyzed CAP discharge data from October 2002 through March 2005. The data was provided by ACTrackerTM, an online tool that provides national estimates of hospital and drug utilization approximately 45 days after the end of each month, making the estimates the most timely and current of their kind.

In the 2004-2005 flu season, daily CAP discharges peaked at an average of about 7,000 and 8,000, respectively, in January/February 2005 compared to the previous flu season's December 2003/January 2004 peak. Both these seasons had approximately 31 percent more hospital discharges than the 2002-2003 flu season.

Due to an unusual shortage of flu vaccine, the later peak of the 2004-2005 flu season may have been beneficial, allowing public health officials more time to reallocate and administer the limited supply of vaccine to those most in need -- the elderly and children. This extra time could have been responsible for preventing many more people from becoming ill than would have been expected under the circumstances if the flu peaked at the same time it did the year before.


To see a graph showing hospital CAP admissions for 2002-2005, go to


Source:Solucient, LLC

Page: 1

Related biology news :

1. Study reveals genomics of inflammation from severe injury
2. Study shows pine bark naturally decreases severe chronic venous insufficiency
3. New treatment for severe malaria
4. Highly concentrated botulinum preparation for cosmetic injections can result in severe illness
5. Hopkins scientists link immune response to ghost parasites and severely congested sinuses
6. New findings could lead to vaccine for severe malaria
7. MRSA toxin acquitted: Study clears suspected key to severe bacterial illness
8. Mutant gene causes severe kidney disease in infants
9. Stanford-led study closes in on genes that may predispose some people to severe depression
10. Amazon rainforest greens up in the dry season
11. Air travel and flu: Post-9/11 restrictions delayed start of season
Post Your Comments:

(Date:5/12/2016)... , a brand of Troubadour Research & ... Q1 wave of its quarterly wearables survey. A particular ... a program where they would receive discounts for sharing ... "We were surprised to see that so many ... CEO of Troubadour Research, "primarily because there are segments ...
(Date:4/28/2016)... BANGALORE, India , April 28, 2016 /PRNewswire/ ... product subsidiary of Infosys (NYSE: INFY ), and ... global partnership that will provide end customers with ... banking and payment services.      (Logo: ... area for financial services, but it also plays a fundamental ...
(Date:4/26/2016)... , April 27, 2016 ... the  "Global Multi-modal Biometrics Market 2016-2020"  report to ... ) , The analysts forecast the ... CAGR of 15.49% during the period 2016-2020.  ... number of sectors such as the healthcare, BFSI, ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... --  Ginkgo Bioworks , a leading organism design ... awarded as one of the World Economic Forum,s ... innovative companies. Ginkgo Bioworks is engineering biology to ... in the nutrition, health and consumer goods sectors. ... including Fortune 500 companies to design microbes for ...
(Date:6/24/2016)... ... ... Researchers at the Universita Politecnica delle Marche in Ancona combed medical journal ... Their findings are the subject of a new article on the Surviving Mesothelioma website. ... the blood, lung fluid or tissue of mesothelioma patients that can help point doctors ...
(Date:6/23/2016)... /PRNewswire/ - FACIT has announced the creation of ... company, Propellon Therapeutics Inc. ("Propellon" or "the Company"), ... portfolio of first-in-class WDR5 inhibitors for the treatment ... represent an exciting class of therapies, possessing the ... cancer patients. Substantial advances have been achieved with ...
(Date:6/23/2016)... , June 23, 2016  The Prostate Cancer Foundation (PCF) is ... treatments and faster cures for prostate cancer. Members of the Class of 2016 ... countries. Read More About the Class of 2016 PCF ... ... ...
Breaking Biology Technology: